NCT05460780 (TIDE) is a NA clinical trial of MATTISSE TEC in Breast Cancer Female, sponsored by Quanta Medical.

Who is sponsoring NCT05460780?

NCT05460780 is sponsored by Quanta Medical.

What drugs are being tested in NCT05460780?

Interventions in NCT05460780: MATTISSE TEC.

What condition does NCT05460780 study?

NCT05460780 studies Breast Cancer Female, Breast Cancer Prevent, Breast Reconstruction.

Is NCT05460780 still recruiting?

NCT05460780 is currently recruiting now. Last updated 20 March 2025.

Last reviewed 2025-03-20 · How we verify

NCT05460780: TIDE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

First-in-human, Study of MATTISSE® Tissue Engineering Chamber in Adult Female Patients Undergoing Breast Reconstruction After Mastectomy for Cancer

Recruiting now NA Last updated 20 March 2025

What this trial tests

NA trial testing MATTISSE TEC in Breast Cancer Female in 50 participants. Currently enrolling.

Timeline

1 July 2022

Primary endpoint
31 July 2027

31 December 2028

Quick facts

Lead sponsor	Quanta Medical
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	50
Start date	1 July 2022
Primary completion	31 July 2027
Estimated completion	31 December 2028
Sites	3 locations across Georgia, France

Drugs / interventions tested

MATTISSE TEC

Conditions studied

Breast Cancer Female — all drugs for Breast Cancer Female →
Breast Cancer Prevent — all drugs for Breast Cancer Prevent →
Breast Reconstruction — all drugs for Breast Reconstruction →

Sponsor

Quanta Medical — full company profile →

Who can join

18 and older, female only, with Breast Cancer Female or Breast Cancer Prevent. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a first in human, two-stage single arm non-comparative study of safety and performance. The aim of the study is to asses the safety and the clinical performance of a new device : the MATTISSE tissu engineering chamber.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

State of Research on Tissue Engineering with 3D Printing for Breast Reconstruction.
De Sario Velasquez GD, Tanas Y, Taraballi F, Herzog T, et al · · 2025 · cited 1× · PMID 41095816 · DOI 10.3390/jcm14196737

Verify or expand the search:

Other recruiting trials for Breast Cancer Female

Currently open trials in the same condition.

NCT07505797 — ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) · recruiting
NCT07198724 — ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrin · Phase 1, PHASE2 · recruiting
NCT07331506 — Validation of the Oncoliq Test for the Early Detection of Breast Cancer. · recruiting
NCT07214883 — UCF MammoChat: Image Repository · recruiting
NCT07120100 — Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Surviv · NA · recruiting

Other Quanta Medical trials

Trials by the same sponsor.

NCT04407338 — Efficacy and Tolerance Study of B-DYN Versus Conventional Fusion in the Treatment of Lumbar Stenosis on the Degree of Po · NA · recruiting
NCT04033055 — Antalgic Efficacy of CycloMesh™ Soaked in Ropivacaine Hydrochloride in Uncomplicated Inguinal Hernia. · NA · completed
NCT03752671 — Efficacy and Safety of IntraSPINE® Associated With Discectomy in the Treatment of Lumbar Disc Herniation. · NA · completed
NCT03642171 — Surveillance Study of the Contraceptive Intrauterine Device UT380® · completed
NCT03612011 — Efficacy of the Cosmetic Product "Onco-Repair" on Grade 2 Hand Foot Syndrome · Phase 3 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05460780 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Quanta Medical
Last refreshed: 20 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05460780.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing